Document is current
Any future updates will be listed below
-
Authors
Sun, Benjamin B.
Maranville, Joseph C.
Peters, James E.
Stacey, David
Staley, James R.
Blackshaw, James
Burgess, Stephen
Jiang, Tao
Paige, Ellie
Surendran, Praveen
Oliver-Williams, Clare
Kamat, Mihir A.
Prins, Bram P.
Wilcox, Sheri K.
Zimmerman, Erik S.
Chi, An
Bansal, Narinder
Spain, Sarah L.
Wood, Angela M.
Morrell, Nicholas W.
Bradley, John R.
Janjic, Nebojsa
Roberts, David J.
Ouwehand, Willem H.
Todd, John A.
Soranzo, Nicole
Suhre, Karsten
Paul, Dirk S.
Fox, Caroline S.
Plenge, Robert M.
Danesh, John
Runz, Heiko
Butterworth, Adam S.
- License Information
-
More Information
Article History
Received: 28 March 2017
Accepted: 27 April 2018
First Online: 6 June 2018
Competing interests
: The authors declare the following competing interests: A.C., CSF-Merck employee; N.J., S.K.W., SomaLogic Inc employees and stakeholders; E.S.Z., SomaLogic Inc employee; J.C.M., R.M.P., Merck employees during this study, now Celgene employees; H.R., Merck employee during this study; J.E.P., travel and accommodation expenses and hospitality from Olink to speak at Olink-sponsored academic meetings; A.S.B., grants from Merck, Pfizer, Novartis, Biogen and Bioverativ and personal fees from Novartis; J.D., sits on the Novartis Cardiovascular and Metabolic Advisory Board, had grant support from Novartis.
